PDCD1 and hepatocellular carcinoma: WTAP knockdown alleviates CD8+ T cell exhaustion and improves anti-PD-1 therapeutic efficacy, demonstrating that WTAP drives hepatocellular carcinoma progression and attenuates antitumor immunity via epitranscriptomic regulation of PD-1 translation (67).